---
title: "X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294736223.md"
description: "X4 Pharmaceuticals issued inducement stock options for 12,000 shares to new employees under its 2019 Inducement Equity Incentive Plan. The options have a 10-year term with an exercise price of $3.98 per share, based on the July 31 closing price. Vesting occurs over four years: 25% after 12 months, followed by monthly vesting over the remaining 36 months, contingent on continued employment."
datetime: "2026-08-03T20:39:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294736223.md)
  - [en](https://longbridge.com/en/news/294736223.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294736223.md)
generator: "portal-rs"
---

# X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 each

-   X4 Pharmaceuticals issued inducement stock options covering 12,000 shares to new employees under its 2019 Inducement Equity Incentive Plan. \* Options carry a 10-year term with an exercise price of USD 3.98 per share, set at the July 31 close. \* Vesting runs four years: 25% after 12 months, then monthly over the next 36 months, subject to continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031630PRIMZONEFULLFEED9802703) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [XFOR.US](https://longbridge.com/en/quote/XFOR.US.md)

## Related News & Research

- [XCharge plans 1-for-20 reverse ADS split via ratio change effective Aug. 21](https://longbridge.com/en/news/296347969.md)
- [ADM announces Q3 2026 distribution of R$ 0.22 per unit, payable Sept. 15](https://longbridge.com/en/news/296399586.md)
- [Silver Stocks Screened For Tight Supply And AI Demand](https://longbridge.com/en/news/296702102.md)
- [Signaux Girod reports 1,032,500 shares outstanding, 1,051,466 theoretical voting rights as of July 31](https://longbridge.com/en/news/296448329.md)
- [Scinai Immunotherapeutics changes ADS ratio in move equivalent to 1-for-10 reverse split](https://longbridge.com/en/news/296363246.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**